Molecular Imaging

Group members Research lines Articles Projects Other publications

1. Molecular Imaging od Glucose Metabolism in Oncology.

  • Imaging Criteria for measuring the Metabolic Response to treatment in Oncology.
  • Assessment of the role of 18F-FDG PET/CT on the effect of biologic therapy in solid tumours.
  • Tissue characterization of pulmonary lesions by 18F-FDG PET/CT.
  • Assessment of the role of 18F-FDG PET/CT to the nodal staging of lung cancer.

2. Molecular Imaging in the study assessment of the mineralization and inflammation of the carotid atheroma plaque.

  • To define an acquisition protocol of 18F-FDG PET/CT to study the carotid plaque metabolism
  • To assess the inflammation process of the carotid plaque by 18F-FDG PET/CT
  • To assess the calcification process of the carotid plaque by 18FNa PET/CT
  • To monitor the response to anti-inflammatory treatment by 18F-FDG PET/CT
  • To study the carotid plaque stability and to identify the vulnerable plaque by molecular imaging techniques

3. Assessment and evaluation of the clinical impact of 18F-FNa PET/CT and 18F-FDG PET/CT in the management of atherosclerosis in diabetic patients.

  • To establish an acquisition protocol for 18F-FNa PET/CT and 18F-FDG PET/CT for the study of atherosclerosis in diabetic patients
  • To identify uptake patterns in different vascular territories of the body in diabetic patients 
  • To evaluate the correlation between the arterial uptake of 18F-Fna and cardiovascular risk factor of diabetes.

4. Molecular Imaging of the protein b-amyloid in the study of the cognitive impairment and assessment of its clinical impact.

  • Identification of patients with Alzheimer´s disease 
  • To establish an acquisition protocol for b-amyloid imaging using 11C-PIB PET/CT 
  • To determine the 11C-PIB retention patterns in the brain
  • To study the contribution of 11C-PIB PET/CT in the study of cognitive impairment
  • To identify the patients with b amyloid deposit in the brain
  • To assess the role of 11C-PIB in differential diagnose of dementias
  • To evaluate quantitatively the contribution of 11C-PIB

5. Molecular Imaging in the early diagnosis and extension of vasculitis.

  • To establish an acquisition protocol for 18F-FDG in patients with suspicion of large vessel vasculitis. 
  • To determine the biokinetics of FDG in the large vessels was, to establish the optimum time for image acquisition
  • To identify the normal uptake patterns in different vascular territories
  • To quantify the arterial wall activity in relation to the global vascular activity
  • To calculate the standard uptake values ( SUV ) in normal subjects and in patients with arterial wall inflammation

6. Research and Development of new molecular imagen radiotracers.

  • To study the application of radiotracers for prostate cancer recurrence
  • To assess the role of 11C-methionine in primary hyperparathyroidism
  • To evaluate the role of 11C-methionine in the suspicion of brain tumour recurrence
  • To carry out the synthesis and clinical and to assess the clinical contribution of 18F-FLT
  • To carry out the synthesis and develop.
Gobierno de Cantabria  Servicio Cántabro de Salud  Hospital Universitario Marqués de Valdecilla   Universidad de Cantabria    Instituto de Salud Carlos III 
INSTITUTO DE INVESTIGACIÓN MARQUÉS DE VALDECILLA
Edificio IDIVAL, Avenida Cardenal Herrera Oria s/n,
39011 Santander (CANTABRIA).

Phone.: 942 31 55 15
Fax: 942 31 55 17

 

  • LINKS


EVENTS
events